Alcon to acquire cataract laser treatment company for $430m
Alcon has announced that it will acquire LENSAR, a stock listed company specializing in the advanced laser treatment of cataracts, following an agreement between both companies. The Swiss-based eye care group will purchase all LENSAR outstanding shares with a 24 percent premium to their average price of the last 30 ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.